Close menu
- Home
- News
- Research
- Opinion
- Features
- Culture
- Careers
- Podcasts
- Webinars
-
Collections
- Back to parent navigation item
- Collections
- The future of energy storage
- AI and automation in chemistry
- Sustainable labs
- Research culture
- Coronavirus
- Nobel prize
-
Themed supplements
- Back to parent navigation item
- Themed supplements
- Problem solvers
- Inspiring science
- Up to the challenge
- Eureka moments
- Chemistry 4.0
- Forefront of pharma
- Collaborative chemistry
- Everyday chemistry
- Future of pharma
- Voices in chemistry
- Chemistry detectives
- Innovators
- Green and sustainable chemistry
- Health technology
- View all
- Partner collections
- Register
GSK and Pfizer joint venture creates new consumer healthcare giant
By Anthony King2018-12-21T14:47:00
Source: © Willy Barton/Shutterstock.com
Enlarged GSK consumer health will have largest market share of any firm and be a leader in key countries
A new $9.8 billion (£7.7 billion) consumer health business has been created by GlaxoSmithKline (GSK) and Pfizer. The joint venture brings together the consumer brands of Pfizer and GSK to make it a global leader in over-the-counter products.
- This website collects cookies to deliver a better user experience. See how this site uses cookies.
- This website collects cookies to deliver a better user experience. Do not sell my personal data.
- Este site coleta cookies para oferecer uma melhor experiência ao usuário. Veja como este site usa cookies.
Site powered by Webvision Cloud